Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6751
CALL
Appian
APPN
$2.63B
| $1.33M | ﹤0.01% |
37,500
-5,100
| -12% | -$182K |
|
6752
CALL
Halozyme
HALO
$11.9B
| $1.33M | ﹤0.01% |
19,700
-31,300
| -61% | -$2.11M |
|
6753
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$270M
| $1.33M | ﹤0.01% |
+19,386
| New | +$1.3M |
|
6754
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.61B
| $1.32M | ﹤0.01% |
43,750
+29,142
| +199% | +$862K |
|
6755
Franklin International Aggregate Bond ETF
FLIA
$763M
| $1.32M | ﹤0.01% |
65,591
-33,264
| -34% | -$684K |
|
6756
Malibu Boats
MBUU
$573M
| $1.32M | ﹤0.01% |
46,890
-6,217
| -12% | -$180K |
|
6757
CALL
Mohawk Industries
MHK
$9.03B
| $1.32M | ﹤0.01% |
12,100
-59,200
| -83% | -$6.8M |
|
6758
CALL
Invesco S&P 500 Top 50 ETF
XLG
$10.8B
| $1.32M | ﹤0.01% |
22,300
-3,000
| -12% | -$176K |
|
6759
CALL
AdvanSix
ASIX
$448M
| $1.32M | ﹤0.01% |
76,300
+61,700
| +423% | +$1.08M |
|
|
TIER
6760
T. Rowe Price International Equity Research ETF
TIER
$42.5M
| $1.32M | ﹤0.01% |
46,714
+2
| +0% | +$55 |
|
6761
PUT
Trupanion
TRUP
$1.32B
| $1.32M | ﹤0.01% |
35,300
-32,200
| -48% | -$1.26M |
|
6762
PUT
Atlas Energy Solutions
AESI
$1.57B
| $1.32M | ﹤0.01% |
139,800
-40,800
| -23% | -$413K |
|
6763
PUT
Direxion Daily Healthcare Bull 3X ETF
CURE
$194M
| $1.32M | ﹤0.01% |
11,800
-1,800
| -13% | -$184K |
|
|
HPP
6764
CALL
Hudson Pacific Properties
HPP
$748M
| $1.31M | ﹤0.01% |
121,378
+12,664
| +12% | +$188K |
|
6765
PUT
Spire Global
SPIR
$566M
| $1.31M | ﹤0.01% |
175,200
+8,700
| +5% | +$85.1K |
|
|
LENZ
6766
PUT
LENZ Therapeutics
LENZ
$153M
| $1.31M | ﹤0.01% |
82,100
+57,200
| +230% | +$1.67M |
|
6767
Old Second Bancorp
OSBC
$1.31B
| $1.31M | ﹤0.01% |
67,313
-10,275
| -13% | -$192K |
|
6768
Nuveen Core Plus Bond ETF
NCPB
$55.2M
| $1.31M | ﹤0.01% |
51,985
+9,476
| +22% | +$240K |
|
6769
JELD-WEN Holding
JELD
$161M
| $1.31M | ﹤0.01% |
533,437
+221,767
| +71% | +$728K |
|
6770
Hope Bancorp
HOPE
$1.82B
| $1.31M | ﹤0.01% |
119,708
-62,588
| -34% | -$674K |
|
6771
Plumas Bancorp
PLBC
$432M
| $1.31M | ﹤0.01% |
29,348
+15,844
| +117% | +$680K |
|
6772
CALL
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
| $1.31M | ﹤0.01% |
23,500
-5,700
| -20% | -$324K |
|
|
PIPE
6773
Invesco SteelPath MLP & Energy Infrastructure ETF
PIPE
$68M
| $1.31M | ﹤0.01% |
54,461
-564
| -1% | -$13.4K |
|
6774
CALL
Clover Health Investments
CLOV
$2.25B
| $1.31M | ﹤0.01% |
557,600
-482,700
| -46% | -$1.32M |
|
|
TOPW
6775
Roundhill Top WeeklyPay ETF
TOPW
$141M
| $1.31M | ﹤0.01% |
+31,290
| New | +$1.54M |
|
Similar funds
Ken Griffin's Q4 2025 Portfolio in Review
As of Q4 2025, Ken Griffin held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Ken Griffin added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Ken Griffin's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Ken Griffin fully exited WEX in Q4 2025, selling an estimated $131M.
- Ken Griffin's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Ken Griffin opened 2,078 new positions and closed 2,191 in Q4 2025.
- Ken Griffin's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.